jk
and in PMR pharmaceutical market reports covering Central and Eastern Europe:Diet supplements market Romania 2010
The changes in the lifestyles of Romanians, with healthier diets and bio (health) products becoming more common, have boosted the dietary supplement market in recent years. However, in 2009, mainly as a result of the economic difficulties which the country experienced after the financial meltdown, the growth of the dietary supplement market slowed significantly, increasing by only 1% in final prices in comparison with the previous year, according to PMR’s report: “Dietary supplement market in Romania 2010. Development forecasts for 2010-2013”.
Private healthcare market Poland 2010
In 2009 the Polish private healthcare market was worth PLN 27.9bn (€6.4bn), up by ca. 8% on 2008, according to the report by PMR, a research and consulting company, entitled “Private healthcare market in Poland 2010. Development forecasts for 2010-2012”. Despite the economic crisis, which has impeded the rate of growth on the medical subscriptions market in Poland, the leading private medical companies developed their outpatient and inpatient medical services rapidly in 2009. The phenomenon of opening hospitals was new at that time – in the past, those who led the field in sales of medical subscriptions did not operate their own hospitals.
Clinical trials Poland 2010
In 2010, the clinical trials market in Poland is expected to grow by 5% year on year, and to reach PLN 718m (€170m), according to the report by PMR, a research and consulting company, entitled “Clinical trials in Poland 2010. Development forecasts for 2010-2012”. If barriers to market growth, including unclear legislation and difficult trial registration procedures at the Central Register of Clinical Trials (the CEBK), were removed, the clinical trials market could develop even more rapidly.
Clinical trials Poland 2010
The clinical trials market in Poland slowed in 2009, in comparison with previous years. Between 2006 and 2008, it grew at a rate of 8-10% per annum, whereas 2009 saw a year-on-year increase of only 1%, according to the report by PMR, a research and consulting company, entitled “Clinical trials in Poland 2010. Development forecasts for 2010-2012”. PMR forecasts that in 2010 the market will expand by around 5% year on year and will be worth PLN 718m (€170m).
Distribution on the pharmaceutical market in Central Europe 2010
The most important trends and events in distribution in the Central European region in 2009, according to the report by PMR, a research and consulting company, entitled “Distribution on the pharmaceutical market in Central Europe 2010. Comparative analysis of Poland, Hungary, Romania, Czech Republic, Slovakia and Bulgaria”, were the fall in the number of pharmacies in Poland, the Czech Republic, Hungary and Bulgaria, the consolidation processes among leading Polish wholesalers and the authorisation of the online sale of pharmaceuticals in Slovakia.
Private healthcare market Romania 2010
Development of health insurance is expected to take place in the next few years and to begin to take clients from private healthcare providers in the short term. The corporate subscription market is believed to have reached saturation, and some customers might switch in future years to private health insurance, which is believed to be more comprehensive than the services offered by a network of medical facilities. However, this will depend largely on the expansion of private healthcare facilities in the country, according to estimates included in the report “Private healthcare market in Romania 2010. Development forecasts for 2010-2012” by PMR, a research and consulting company.
Distribution on the pharmaceutical market in Poland 2010
According to the report by the research and consulting company PMR, “Distribution on the pharmaceutical market in Poland 2010. Development forecasts for 2010-2012”, during the period 2008-2009 the pharmaceutical distribution sector in Poland saw further consolidation, both among distributors and among retailers. The most important event in the wholesale distribution segment was the buyout of Prosper by Torfarm, another leading distributor on the Polish market, in April 2009. After the fusion, the two companies together control more than 30% of the market of distribution to pharmacies in Poland.
In vitro diagnostics market in Poland 2010
Generic and innovative drugs markets in Central and Eastern Europe 2009
OTC market in Central and Eastern Europe 2009
Biotechnological innovations in the pharmaceutical industry in Poland 2009
Pharmaceutical and healthcare market in Poland 2009
Private healthcare market in Poland 2009
Private healthcare market in Central and Eastern Europe 2009
to see all PMR pharmaceutical market reports visit PMR Publications on-line shop.